3-cyanoquinolines as inhibitors of egf-r and her2 kinases

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 215/54 (2006.01) A61K 31/47 (2006.01) A61P 35/00 (2006.01) C07D 215/56 (2006.01)

Patent

CA 2467573

This invention provides compounds of Formula (I), represented by the structure wherein G1, G2, G3, G4, Z, X and n are defined herein, or a pharmaceutically acceptable salt thereof which are useful as antineoplastic agents and in the treatment of polycystic kidney disease.

L'invention concerne des composés de formule (I), représentés par la structure dans laquelle G¿1?, G¿2?, G¿3?, G¿4?, Z, X et n sont définis dans la description, ou un sel de ces composés, acceptable sur le plan pharmaceutique, qui sont utiles en tant qu'agents antitumoraux et dans le traitement de maladie polykystique des reins.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

3-cyanoquinolines as inhibitors of egf-r and her2 kinases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3-cyanoquinolines as inhibitors of egf-r and her2 kinases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-cyanoquinolines as inhibitors of egf-r and her2 kinases will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1821328

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.